Various pharmaceutical products / 2024-2025

Finnish Institute for Health and Welfare, later referred to as THL or Customer, requested tenders for Various pharmaceutical products to the rescEU project. The Scope of procurement is described in more detail in Annex 1 to the Call for tenders. The procurement is divided in fifteen (15) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. - LOT 1: Morphine 10-20 mg/ml (1-5 ml per vial/ampoule, i.m., ATC N02AA01) - LOT 2: Ondansetron 2 mg/ml (2-4 ml per vial/ampoule, i.m. and i.v., ATC A04AA01) - LOT 3: Ondansetron 4-8 mg per tablet/capsule, oral (ATC A04AA01) - LOT 4: Hydrocortisone 250 mg / 2 ml (2 ml per vial/ampoule i.v., ATC H02AB09) - LOT 5: Epinephrine (Adrenaline) 1 mg/ml (1-5 ml per vial/ampoule, i.v. and i.m., ATC C01CA24) - LOT 6: Diazepam 10 mg / 2 ml (2 ml per vial/ampoule, i.m. and i.v., ATC N05BA01) - LOT 7: Midazolam 1-5 mg/ml (3-10 ml per vial/ampoule, i.v., ATC N05CD08) - LOT 8: Salbutamol 200 µg/dose (inhaler, 60 or 200 doses, ATC R03AC02) - LOT 9: Budesonide 0,5 mg/ml (2 ml nebuliser suspension per respule, ATC R03BA02) - LOT 10: Ciprofloxacin 2 mg/ml (100-200 ml per vial/ampoule, i.v., ATC J01MA02) - LOT 11: Streptomycin 1 g per vial/ampoule, i.m. (ATC J01GA01) - LOT 12: Meropenem 500-1000 mg per vial/ampoule, i.v. (ATC J01DH02) - LOT 13: Clindamycin 600 mg / 4 ml (4 ml per vial/ampoule, i.m. and i.v., ATC J01FF01) - LOT 14: Ciprofloxacin 250-500 mg per tablet/capsule, oral (ATC J01MA02) - LOT 15: Ethanol 95-96 % (5-20 ml per vial/ampoule, i.v., ATC V03AB16) The minimum requirements for the products is described in Annex 1.1 to the Call for tenders. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the contract has been signed by Contracting parties and expires when all contractual duties of the Contract have been performed. Estimated quantity for the products is described in Annex 6 (restricted to security classification level IV, TL IV) to the Call for tenders. In addition to the estimated quantity indicated in the Annex 6, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The Supplier is not obliged to deliver the products under the Option. Please note that all times given in the Call for tenders refer to local time in Finland. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Contract Annex 3 Security annex Annex 4 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 5 Confidentiality commitment Annex 6 Estimated quantity (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract and the Call for tenders.

The availability for the Annex 6 is restricted to security classification level IV (TL IV). THL will send the Annex 6 to a representative of the tenderer via encrypted e-mail after THL has received a scanned version of the signed confidentiality commitment (Annex 5). The signature of the confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the e-mail address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/1198/2.02.06/2024 / Various pharmaceutical products". The message shall contain name of the tenderer and e-mail address to which the Annex 6 is to be sent.